Advanced search
Publication Cover
Pharmaceutical Biology Volume 55, 2017 - Issue 1
Submit an article Journal homepage
2,324
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study

Lu LiuDepartment of Endocrinology, Seventh People's Hospital of Shanghai University of TCM, Shanghai, China; View further author information
,
Xiaolan YinGamaknife Center, No 411 Hospital of the Chinese People's Liberation Army, Shanghai, China; View further author information
,
Xu WangDepartment of CT, First Affiliated Hospital of Nanyang Medical College, Nanyang, Henan, ChinaView further author information
&
Xiaohua LiDepartment of Endocrinology, Seventh People's Hospital of Shanghai University of TCM, Shanghai, China; Correspondence[email protected]
View further author information
Pages 657-662 | Received 24 Jun 2016, Accepted 26 Nov 2016, Published online: 12 Dec 2016

References

  • Bi W, He C, Ma Y, Shen J, Zhang LH, Peng Y, Xiao P. 2016. Investigation of free amino acid, total phenolics, antioxidant activity and purine alkaloids to assess the health properties of non-Camellia tea. Acta Pharm Sin B. 6:170–181.
  • Chen J, Wu Y, Zou J, Gao K. 2016. α-Glucosidase inhibition and antihyperglycemic activity of flavonoids from Ampelopsis grossedentata and the flavonoid derivatives. Bioorg Med Chem. 24:1488–1494.
  • Chen S, Zhao X, Wan J, Ran L, Qin Y, Wang X, Gao Y, Shu F, Zhang Y, Liu P, et al. 2015. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial. Pharmacol Res. 99:74–81.
  • Du Q, Cai W, Xia M, Ito Y. 2002. Purification of (+)-dihydromyricetin from leaves extract of Ampelopsis grossedentata using high-speed countercurrent chromatograph with scale-up triple columns. J Chromatogr A. 973:217–220.
  • Hou X, Tong Q, Wang W, Xiong W, Shi C, Fang J. 2015. Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways. Life Sci. 130:38–46.
  • Hou XL, Tong Q, Wang WQ, Shi CY, Xiong W, Chen J, Liu X, Fang JG. 2015. Suppression of inflammatory responses by dihydromyricetin, a flavonoid from Ampelopsis grossedentata, via inhibiting the activation of NF-κB and MAPK signaling pathways . J Nat Prod. 78:1689–1696.
  • Hu M. 2007. Commentary: bioavailability of flavonoids and polyphenols: call to arms. Mol Pharm. 4:803–806.
  • Huang H, Hu M, Zhao R, Li P, Li M. 2013. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway. Oncol Rep. 30:2467–2475.
  • Ji FJ, Tian XF, Liu XW, Fu LB, Wu YY, Fang XD, Jin HY. 2015. Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells. Genet Mol Res. 14:15564–15571.
  • Jiang B, Le L, Pan H, Hu K, Xu L, Xiao P. 2014. Dihydromyricetin ameliorates the oxidative stress response induced by methylglyoxal via the AMPK/GLUT4 signaling pathway in PC12 cells. Brain Res Bull. 109:117–126.
  • Jiang L, Zhang Q, Ren H, Ma S, Lu C, Liu B, Liu J, Liang J, Li M, Zhu R. 2015. Dihydromyricetin enhances the chemo-sensitivity of nedaplatin via regulation of the p53/bcl-2 pathway in hepatocellular carcinoma cells. PLoS One. 10:e0124994.
  • Li YS. 2006. Effects of Enshi-Ampelopsis Grossede on serum lipid and blood rheology and oxygen free radical of hyperlipidemia model rats. J Hubei Inst Natl Med Ed. 23:7–9.
  • Meng G, Yang S, Chen Y, Yao W, Zhu H, Zhang W. 2015. Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner. Pharm Biol. 53:904–912.
  • Qin J, Zhong Z, Zhou G, Chen X. 2001. The experimental studies of dihydromyricetin on antidiabetic effect. Chin J Mod Appl Pharm. 18:351–351.
  • Tong Q, Hou X, Fang J, Wang W, Xiong W, Liu X, Xie X, Shi C. 2015. Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. J Pharm Biomed Anal. 114:455–461.
  • Wang CG, Tong Q, Hou XL, Hu SY, Fang JG, Sun CQ. 2016. Enhancing bioavailability of dihydromyricetin through inhibiting precipitation of soluble cocrystals by a crystallization inhibitor. Crystal Growth Design. 16:5030–5039.
  • Xia J, Guo S, Fang T, Feng D, Zhang X, Zhang Q, Liu J, Liu B, Li M, Zhu R. 2014. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways. Food Chem Toxicol. 66:7–13.
  • Zhang YS, Zhang QY, Li LY, Wang B, Zhao YY, Guo DA. 2007. Simultaneous determination and pharmacokinetic studies of dihydromyricetin and myricetin in rat plasma by HPLC-DAD after oral administration of Ampelopsis grossedentata decoction. J Chromatogr B Anal Technol Biomed Life Sci. 860:4–9.
  • Zhong S, Kong Y, Zhou L, Zhou C, Zhang X, Wang Y. 2014. Efficient conversion of myricetin from Ampelopsis grossedentata extracts and its purification by MIP-SPE. J Chromatogr B Anal Technol Biomed Life Sci. 945/946:39–45.
  • Zou D, Chen K, Liu P, Chang H, Zhu J, Mi M. 2014. Dihydromyricetin improves physical performance under simulated high altitude. Med Sci Sports Exerc. 46:2077–2084.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.